Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06106191 · ClinicalTrials.gov registry record · NA
Integrative Mindfulness-Based Predictive Approach for Chronic Low Back Pain Treatment
A NA study of Chronic Low Back Pain, sponsored by Boston Medical Center.
- Recruiting
- Registry status
- NA
- Development phase
- 350
- Enrollment target
- 1
- Study location
NCT06106191: Recruiting NA study of Chronic Low Back Pain, sponsored by Boston Medical Center.
NCT06106191 is a NA study of Chronic Low Back Pain that is actively recruiting participants, run by Boston Medical Center. The registered enrollment target is 350 participants, below the 587-participant average among 71 other Chronic Low Back Pain trials with a reported enrollment target (40% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06106191, a NA study of Chronic Low Back Pain, is actively recruiting participants, sponsored by Boston Medical Center.
- RECRUITING
- Registry status
- NA
- Development phase
- 350 participants
- Enrollment target
- 1
- Study location
Study Summary
This study will identify unique signatures that people have which can cause pain by evaluating biological, psychological, and social markers using artificial intelligence. These markers can be used to accurately predict the response of diverse individuals with chronic low back pain (cLBP) to Mindfulness-Based Stress Reduction. This will help enhance clinician decision-making and the targeted treatment of chronic pain. The overall objective is to use a unique machine learning (ML) approach to determine the biomarker signature of persons undergoing mindfulness based stress reduction (MBSR) treatment for their chronic low back pain (cLBP). This signature will facilitate clinical prediction and monitoring of patient response to MBSR treatment. The design of the study is a single-arm clinical trial of the evidence-based MBSR program for patients with cLBP.
Primary Outcome
The PEG is a 3-question scale: "pain average", "interference with general activity" and "interference with enjoyment of life". Each question is on a 0-10 scale, and total PEG is the average. Scores can range from 0-30 and \<12=Mild,12 to \<21 = Moderate, 21 to 30 = Severe chronic pain.
Conditions Studied
Interventions
- OTHER Discussion
- BEHAVIORAL Mindfulness meditation
- OTHER Perspectives on pain
Study Locations (1)
Massachusetts
- Boston Medical Center - Boston
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 350 participants |
| Start Date | 2024-07-25 |
| Est. Completion | 2029-12 |
| Phase | NA |
What NCT06106191 shows while recruiting
NCT06106191 is an interventional study that assigns participants to a tested intervention. The registered 350 participants enrollment target is mid-sized for trials with a published cap, below the 587-participant average among 71 other Chronic Low Back Pain trials with a reported enrollment target (40% lower).
The record links to 1 condition, with Chronic Low Back Pain appearing as the primary indexed condition, and to 3 interventions - of which Discussion is the first listed.
NCT06106191 reports a single indexed study location in Massachusetts.
Frequently Asked Questions
What is clinical trial NCT06106191 about?
NCT06106191 is a clinical study titled "Integrative Mindfulness-Based Predictive Approach for Chronic Low Back Pain Treatment". This study will identify unique signatures that people have which can cause pain by evaluating biological, psychological, and social markers using artificial intelligence. These markers can be used to accurately predict the response of diverse individuals with chronic low back pain (cLBP) to Mindful...
What is the current status of trial NCT06106191?
This trial is currently recruiting. It is a NA study. The enrollment target is 350 participants. The study started on 2024-07-25. Estimated completion is 2029-12.
What conditions does trial NCT06106191 study?
This clinical trial studies the following conditions: Chronic Low Back Pain.
What interventions are being tested in trial NCT06106191?
The interventions under investigation include: Discussion (OTHER), Mindfulness meditation (BEHAVIORAL), Perspectives on pain (OTHER).
Who is sponsoring clinical trial NCT06106191?
This trial is sponsored by Boston Medical Center, which has 253 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06106191 being conducted?
This trial has 1 study location across Massachusetts. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Chronic Low Back Pain
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT06106191's enrollment target sits among peer trials
350 12th of 71 higher than 60 of 71 other Chronic Low Back Pain trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Chronic Low Back Pain trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Mobile Neurofeedback for Low Back Pain
RECRUITING · NA
-
Phenotyping Response to Spinal Cord Stimulation in Chronic Low Back Pain
RECRUITING · NA
-
Active Music-Based Intervention in Patients With Chronic Low Back Pain
RECRUITING · NA
-
Sequential and Comparative Evaluation of Pain Treatment Effectiveness Response
RECRUITING · NA
-
Meditation for Older Adults With Chronic Low Back Pain
RECRUITING · NA
-
MBM andtaVNS for Low Back Pain and Depressive Symptoms
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00900575 · 350 participants · NA
Cervical Cancer Detection Using Optical Spectroscopy
- NCT01627821 · 350 participants · NA
Evaluation of the Jarvik 2000 Left Ventricular Assist System With Post-Auricular Connector--Destination Therapy Study
- NCT02357654 · 350 participants · Phase 4
GnRH for Luteal Support in IVF/ICSI/FET Cycles
- NCT03997370 · 350 participants · Phase 1
Evaluation of Dosing Procedures of Chemotherapy Treatment (Carboplatin) With the Contrast Agent Iohexol
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI